JP2000505088A - ノイラミニダーゼ阻害剤として有用なシクロペンタン置換化合物 - Google Patents
ノイラミニダーゼ阻害剤として有用なシクロペンタン置換化合物Info
- Publication number
- JP2000505088A JP2000505088A JP10501649A JP50164998A JP2000505088A JP 2000505088 A JP2000505088 A JP 2000505088A JP 10501649 A JP10501649 A JP 10501649A JP 50164998 A JP50164998 A JP 50164998A JP 2000505088 A JP2000505088 A JP 2000505088A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- acid
- mmol
- methylcarbonylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/02—Saturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pest Control & Pesticides (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 下記式で表されることを特徴とする化合物、 式中、 Xは、CH2、O又はSであり、 R1は、H、OH、NH2又はOR11であり; R9は、CO2H、SO3H,PO3H2、NO2、これらのエステル又はこれらの塩 であり; R3及びR8は、それぞれ独立して、H、(CH2)nCO2R10、(CH2)mOR1 0 、CON(R10)m、(CH2)nN(R10)m、CH(R10)m、(CH2)n(R10 )m、CH2CH(OR10)CH2OR10、CH(OR10)CH(OR10)CH2 OR10、CH2OR10、CH(OR10)CH2NHR10、CH2CH(OR10)C H2NHR10、CH(OR10)CH(OR10)CH2NHR10又はNR10C(=N R10)N(R10)mであり; ただし、R2、R3及びR8のうち少なくとも1つは、H以外のものであり; R4は、H、(CH2)nOH、(CH2)nNH2、(CH2)nC(=NH)NH2 、(CH2)nNHC(=NR7)NH2、(CH2)nCN又は(CH2)n N3であり; R5は、H、低級アルキル、分枝アルキル、環状アルキル又はCF3であり; R7は、H、OH、CN、NH2又はNO2であり; R10は、H、低級アルキル、低級アルキレン、分枝アルキル、環状アルキル、置 換環状アルキル、 (CH2)n芳香族、(CH2)n置換芳香族であり、mが2の 時、2つのR10基は互いに連結してN−ヘテロ環を形成することもでき; R11は、低級アルキル、分枝アルキル又は(CH2)m芳香族であり; mは1又は2であり; nは0〜4であり; ただし、XがO又はSである時、R3及びR8はCH(OR10)CH(OR10)C H2OR10以外のものである; 並びに、薬理学的に許容されるその塩。 2. 低級アルキル基は、1〜約8の炭素原子を有し;低級アルキレン基は、2 〜約8の炭素原子を有する請求項1記載の化合物。 3. 低級アルキル基は、1〜約3の炭素原子を有し;低級アルキレン基は、2 〜3の炭素原子を有する請求項1記載の化合物。 4. アルキル基は、メチル、エチル、プロピル、イソプロピル、t−ブチル、 シクロペンチル及びシクロヘキシルからなる群より選択され、芳香族基は、フェ ニル及びアルキル置換芳香族基からなる群より選択され;置換シクロアルキル基 は、その環に3〜8個の炭素原子を有しており、1〜6個の炭素原子を有する1 又は2つのアルキル基、水酸基又は両方の基で置換され;アルキレン基は、ビニ ル、1−プロペニル、アリル、イソプロペニル、2−メチル−2−プロペニル及 びシクロペンテニルからなる群より選択される請求項1記載の化合物。 5. 塩は、塩酸、臭化水素、硫酸、硝酸、過塩素酸、フマル酸、マレイン酸、 リン酸、グリコール酸、乳酸、サリチル酸、コハク酸、トルエン−p−スルホン 酸、酒石酸、酢酸、クエン酸、メタンスルホン酸、ギ酸、安息香酸、マロン酸、 ナフタレン−2−スルホン酸、トリフルオロ酢酸及びベンゼンスルホン酸からな る群より選択される酸からのものである請求項1記載の化合物。 6. 塩は、ナトリウム又はアンモニウム塩である請求項1記載の化合物。 7. シス−3−[(メチルカルボニルアミノ)メチル]シクロペンタンカルボ ン酸又はその塩である請求項1記載の化合物。 8. トランス−3−アミノ−c−4−(メチルカルボニルアミノ)メチル−γ −シクロペンタンカルボン酸又はその塩である請求項1記載の化合物。 9. トランス−3−{[(アミノ)(イミノ)メチル]アミノ}−c−4−[ (メチルカルボニルアミノ)メチル]シクロペンタン−γ−カルボン酸又はその 塩である請求項1記載の化合物。 10. 4β−{[(アミノ)(イミノ)メチル]アミノ}−3α−[(2−ヒ ドロキシ−1−メチルカルボニルアミノ)エチル]−1−シクロペンタンカルボ ン酸又はその塩である請求項1記載の化合物。 11. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[(2−ヒ ドロキシ) (1−メチルカルボニルアミノ)エチル]シクロペンタンーγ一カ ルボン酸ナトリウムである請求項1記載の化合物。 12. トランス−3−アミノ−トランス−1−ヒドロキシ−シス−4[(ヒド ロキシメチル)(メチルカルボニルアミノ)メチル]シクロペンタン−γ−カル ボン酸又はその塩である請求項1記載の化合物。 13. トランス−3−{[(アミノ)(イミノ)メチル]アミノ}−トランス −1−ヒドロキシ−シス−4−[(2−ヒドロキシメチル)(1−メチルカルボ ニルアミノ)エチル]シクロペンタン−γ−カルボン酸又はその塩である請求項 1記載の化合物。 14. 3β−アミノ−4α−[(1−メチルカルボニルアミノ)(2,3,4 −トリヒドロキシ)ブチル]シクロペンタンカルボン酸又はその塩である請求項 1記載の化合物。 15. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[(1−メ チルカルボニルアミノ)(2,3,4−トリヒドロキシ)ブチル]−シクロペン タンカルボン酸又はその塩である請求項1記載の化台物。 16. シス−3−{[(アミノ)(イミノ)メチル]アミノ}−トランス−1 −ヒドロキシ−トランス−4−[(1−メチルカルボニルアミノ)(2−トリフ ルオロメチル−カルボニルオキシ)エチル]シクロペンタン−γ−カルボン酸又 はその塩である請求項1記載の化合物。 17. t−3−アミノ−c−4−[(1−メチルカルボニルアミノ) (2− フェニルメトキシ)エチル]−t−1−ヒドロキシシクロペンタンーγ一カルボ ン酸又はその塩である請求項1記載の化合物。 18. c−3−{[(アミノ)(イミノ)メチル]アミノ}−t−1−ヒドロ キシ−t−4−{(メチルカルボニルアミノ){[(メチル)−(メトキシ)ア ミノ]カルボニル}メチル}シクロペンタン−γ−カルボン酸又はその塩である 請求項1記載の化合物。 19. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−{{4−[ (メトキシ)(メチル)アミノ]−1−(メチルカルボニルアミノ−2−オキソ }ブチル}シクロペンタンカルボン酸又はその塩である請求項1記載の化合物。 20. t−3−{[(アミノ)(イミノ)メチル]アミノ}−c−4−[(ジ ェチルアミノカルボニル)(メチルカルボニルアミノ)メチル]−t−1−ヒド ロキシシクロペンタン−γ−カルボン酸又はその塩である請求項1記載の化合物 。 21. t−3−アミノ−c−4−[(ジ−n−プロピルアミノカルボニル)( メチルカルボニルアミノ)メチル]−t−1−ヒドロキシシクロペンタン−γ− カルボン酸又はその塩である請求項1記載の化合物。 22. t−3−{[(アミノ)(イミノ)メチル]アミノ}−c−4−[(ジ −n−プロピルアミノカルボニル)(メチルカルボニルアミノ)メチル]−t− ヒドロキシシクロペンタン−γ−カルボン酸又はその塩である請求項1記載の化 合物。 23. c−3−{[(アミノ)(イミノ)メチル]アミノ}−t−4−[(ジ −n−プロピルアミノカルボニル)(メチルカルボニルアミノ)メチル]−t− 1−ヒドロキシシクロペンタン−γ−カルボン酸又はその塩である請求項1記載 の化合物。 24. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[(ジ−n −プロピルアミノカルボニル)(メチルカルボニルアミノ)−メチル]シクロペ ンタンカルボン酸又はその塩である請求項1記載の化合物。 25. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[(メチル カルボニルアミノ)(3−ペンチルアミノカルボニル)メチル]シクロペンタン カルボン酸又はその塩である請求項1記載の化合物。 26. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[(ジエチ ルアミノカルボニル)(メチルカルボニルアミノ)−メチル]シクロペンタンカ ルボン酸又はその塩である請求項1記載の化合物。 27. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−{[(エチ ル)(プロピル)アミノカルボニル](メチルカルボニルアミノ)メチル}シク ロペンタンカルボン酸又はその塩である請求項1記載の化合物。 28. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−{[(エチ ル)(プロピル)アミノカルボニル](メチルカルボニルアミノ)メチル}シク ロペンタンカルボン酸又はその塩である請求項1記載の化合物。 29. 下記式で表される請求項1記載の化合物。 30. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[1−(1 −メチルカルボニルアミノ)ペント−2−エニル]シクロペンタンカルボン酸又 はその塩である請求項1記載の化合物。 31. 3β−{[(アミノ)(イミノ)メチル]アミノ}−4α−[1−(1 −メチルカルボニルアミノ)ペンチル]シクロペンタンカルボン酸又はその塩で ある請求項1記載の化合物。 32. 薬理学的に許容される担体、及び、インフルエンザウイルスノイラミニ ダーゼを阻害するために有効な量の請求項1記載の化合物からなることを特徴と する、インフルエンザウイルスノイラミニダーゼを阻害する組成物。 33. 薬理学的に許容される担体、及び、インフルエンザウイルスノイラミニ ダーゼを阻害するために有効な量の請求項1記載の化合物からなる組成物を、こ れを必要とする患者に投与する過程からなることを特徴とする、インフルエンザ ウイルスノイラミニダーゼを阻害する方法。 34. 薬理学的に許容される担体、及び、インフルエンザウイルスノイラミニ ダーゼを阻害するために有効な量の請求項1記載の化合物からなる組成物を、こ れを必要とする患者に投与する過程からなることを特徴とする、インフルエンザ ウイルスの感染の治療方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1993096P | 1996-06-14 | 1996-06-14 | |
US60/019,930 | 1996-06-14 | ||
US4401097P | 1997-05-02 | 1997-05-02 | |
US60/044,010 | 1997-05-02 | ||
PCT/US1997/009309 WO1997047194A1 (en) | 1996-06-14 | 1997-06-13 | Substituted cyclopentane compounds useful as neuraminidase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000505088A true JP2000505088A (ja) | 2000-04-25 |
JP3481255B2 JP3481255B2 (ja) | 2003-12-22 |
Family
ID=26692776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50164998A Expired - Fee Related JP3481255B2 (ja) | 1996-06-14 | 1997-06-13 | ノイラミニダーゼ阻害剤として有用なシクロペンタン置換化合物 |
Country Status (20)
Country | Link |
---|---|
US (1) | US6410594B1 (ja) |
EP (1) | EP0933993B1 (ja) |
JP (1) | JP3481255B2 (ja) |
KR (1) | KR20000016669A (ja) |
CN (1) | CN1227466A (ja) |
AT (1) | ATE322163T1 (ja) |
AU (1) | AU723360B2 (ja) |
BR (1) | BR9711095A (ja) |
CA (1) | CA2258217C (ja) |
CZ (1) | CZ412898A3 (ja) |
DE (1) | DE69735634T2 (ja) |
DK (1) | DK0933993T3 (ja) |
ES (1) | ES2263179T3 (ja) |
NO (1) | NO311885B1 (ja) |
NZ (1) | NZ333437A (ja) |
PL (1) | PL330407A1 (ja) |
PT (1) | PT933993E (ja) |
RO (1) | RO121027B1 (ja) |
SK (1) | SK171698A3 (ja) |
WO (1) | WO1997047194A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008163035A (ja) * | 1997-12-17 | 2008-07-17 | Biocryst Pharmaceuticals Inc | ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物 |
JP2009538822A (ja) * | 2006-02-13 | 2009-11-12 | バイオクライスト ファーマシューティカルズ, インコーポレイテッド | 静脈におけるウイルスの治療 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054290A1 (en) * | 1998-04-23 | 1999-10-28 | Abbott Laboratories | Inhibitors of neuraminidases |
US6518305B1 (en) * | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
SK15092000A3 (sk) * | 1998-04-23 | 2001-05-10 | Abbott Laboratories | Pyrolidíny ako inhibítory neuraminidáz |
US6455571B1 (en) * | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
AU1520300A (en) * | 1998-11-05 | 2000-05-29 | Biocryst Pharmaceuticals, Inc. | New cyclopentane and cyclopentene compounds and use for detecting influenza virus |
IL147243A0 (en) | 1999-06-28 | 2002-08-14 | Biocryst Pharm Inc | Process for preparing (-)-(1s,4r) n-protected 4-amino-2-cyclopentene-1-carboxylate esters |
US6593314B1 (en) | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
US6627396B1 (en) | 1999-10-28 | 2003-09-30 | The Regents Of The University Of California | Influenza sensor |
AU2001243253A1 (en) * | 2000-02-24 | 2001-09-03 | Biocryst Pharmaceuticals, Inc. | Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
AU2001252578A1 (en) * | 2000-04-25 | 2001-11-07 | Sankyo Company Limited | Preventives for influenza |
AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
US20060293263A1 (en) | 2003-05-16 | 2006-12-28 | Bbk Bio Corporation | Preparation for preventing contact of pathogenic matter with living organism |
CN101420948A (zh) | 2006-02-13 | 2009-04-29 | 拜奥克里斯特制药公司 | 静脉内抗病毒治疗 |
US20070244193A1 (en) * | 2006-04-12 | 2007-10-18 | Babu Yarlagadda S | Intramuscular antiviral treatments |
US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
US20080194801A1 (en) * | 2007-02-14 | 2008-08-14 | Swanson Basil I | Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses |
IN2012CN10271A (ja) * | 2010-05-27 | 2015-04-10 | Reddy’S Lab Ltd Dr | |
AT510585B1 (de) | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase |
CN102584637B (zh) * | 2011-01-17 | 2014-07-09 | 天津药物研究院 | 帕拉米韦水合物晶体、制备方法、药用组合物及其用途 |
CN102603577A (zh) * | 2011-01-19 | 2012-07-25 | 董慧珍 | 一种抗流感和禽流感药物的衍生物及其用途 |
CN102863359B (zh) * | 2012-05-16 | 2014-05-07 | 常州制药厂有限公司 | 一种抗流感药物的合成方法 |
CN104402754B (zh) * | 2014-11-25 | 2016-03-02 | 广东东阳光药业有限公司 | 作为神经氨酸酶抑制剂的化合物及其在药物中的应用 |
CN104387288B (zh) * | 2014-11-25 | 2016-04-20 | 广东东阳光药业有限公司 | 作为神经氨酸酶抑制剂的化合物及其在药物中的应用 |
CN104496839B (zh) * | 2014-12-03 | 2016-04-20 | 广东东阳光药业有限公司 | 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途 |
CN104447390B (zh) * | 2014-12-03 | 2016-03-02 | 广东东阳光药业有限公司 | 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途 |
CN104496857B (zh) * | 2014-12-10 | 2016-10-12 | 广东东阳光药业有限公司 | 作为神经氨酸酶抑制剂的化合物及其在药物中的应用 |
CN110128288B (zh) * | 2018-02-02 | 2023-07-28 | 浙江九洲药业股份有限公司 | 一种氨基取代的环戊烷甲酸烷基酯衍生物的制备方法 |
WO2023192165A1 (en) * | 2022-03-27 | 2023-10-05 | Tranexamic Technologies, Llc | Tranexamic class arginine and histidine mimics as therapeutic agents |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT979736B (it) | 1972-03-07 | 1974-09-30 | Ethyl Corp | Detersivo contenente un sequestran te e relativo metodo di impiego |
US4426391A (en) | 1982-09-15 | 1984-01-17 | Merck & Co., Inc. | [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa |
JPS59163365A (ja) | 1983-03-08 | 1984-09-14 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物 |
DE3475065D1 (en) | 1983-06-23 | 1988-12-15 | Merck & Co Inc | (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives |
JPS63179835A (ja) | 1986-12-20 | 1988-07-23 | メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | シクロペンタン誘導体 |
WO1991011437A1 (en) | 1990-02-02 | 1991-08-08 | Schering Corporation | 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use |
AU1566192A (en) | 1991-03-12 | 1992-10-21 | Mect Corporation | Synthesis of sialic acid and synthetic intermediate therefor |
JP2951765B2 (ja) | 1991-09-10 | 1999-09-20 | 三共株式会社 | エナミノエステル類およびその製法 |
AU673824B2 (en) | 1992-05-29 | 1996-11-28 | Bayer Aktiengesellschaft | Cyclopentane- and -pentene-beta-amino acids |
US5453533A (en) | 1994-04-14 | 1995-09-26 | The University Of Alabama At Birmingham | Inhibitors of influenza virus neuraminidase and methods of making and using the same |
US5789434A (en) | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
US5602277A (en) * | 1995-03-30 | 1997-02-11 | Biocryst Pharmaceuticals, Inc. | Substituted benzene derivatives useful as neuraminidase inhibitors |
CA2176414A1 (en) | 1995-05-18 | 1996-11-19 | S. David Kimball | Acyl guanidine and amidine prodrugs |
JP2001512439A (ja) | 1997-02-06 | 2001-08-21 | メルク エンド カンパニー インコーポレーテッド | 線維素原受容体拮抗薬プロドラッグ |
AR016162A1 (es) | 1997-12-17 | 2001-06-20 | Biocryst Pharm Inc | Compuestos ciclopentano y ciclopenteno sustituidos que son de utilidad como inhibidores de la neuraminidasa y composicion que los contiene. |
SK15092000A3 (sk) | 1998-04-23 | 2001-05-10 | Abbott Laboratories | Pyrolidíny ako inhibítory neuraminidáz |
WO1999054290A1 (en) | 1998-04-23 | 1999-10-28 | Abbott Laboratories | Inhibitors of neuraminidases |
-
1997
- 1997-06-13 BR BR9711095-7A patent/BR9711095A/pt not_active IP Right Cessation
- 1997-06-13 JP JP50164998A patent/JP3481255B2/ja not_active Expired - Fee Related
- 1997-06-13 WO PCT/US1997/009309 patent/WO1997047194A1/en active IP Right Grant
- 1997-06-13 SK SK1716-98A patent/SK171698A3/sk unknown
- 1997-06-13 CZ CZ984128A patent/CZ412898A3/cs unknown
- 1997-06-13 CN CN97197248A patent/CN1227466A/zh active Pending
- 1997-06-13 NZ NZ333437A patent/NZ333437A/xx unknown
- 1997-06-13 CA CA002258217A patent/CA2258217C/en not_active Expired - Fee Related
- 1997-06-13 RO RO98-01684A patent/RO121027B1/ro unknown
- 1997-06-13 PL PL97330407A patent/PL330407A1/xx unknown
- 1997-06-13 DK DK97931014T patent/DK0933993T3/da active
- 1997-06-13 AT AT97931014T patent/ATE322163T1/de active
- 1997-06-13 DE DE69735634T patent/DE69735634T2/de not_active Expired - Lifetime
- 1997-06-13 AU AU34750/97A patent/AU723360B2/en not_active Ceased
- 1997-06-13 ES ES97931014T patent/ES2263179T3/es not_active Expired - Lifetime
- 1997-06-13 PT PT97931014T patent/PT933993E/pt unknown
- 1997-06-13 EP EP97931014A patent/EP0933993B1/en not_active Expired - Lifetime
- 1997-06-13 KR KR1019980710269A patent/KR20000016669A/ko active IP Right Grant
- 1997-06-13 US US09/202,351 patent/US6410594B1/en not_active Expired - Lifetime
-
1998
- 1998-12-11 NO NO19985821A patent/NO311885B1/no unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008163035A (ja) * | 1997-12-17 | 2008-07-17 | Biocryst Pharmaceuticals Inc | ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物 |
JP2009538822A (ja) * | 2006-02-13 | 2009-11-12 | バイオクライスト ファーマシューティカルズ, インコーポレイテッド | 静脈におけるウイルスの治療 |
Also Published As
Publication number | Publication date |
---|---|
WO1997047194A1 (en) | 1997-12-18 |
DE69735634T2 (de) | 2007-05-03 |
CA2258217A1 (en) | 1997-12-18 |
NO311885B1 (no) | 2002-02-11 |
BR9711095A (pt) | 2001-07-17 |
DE69735634D1 (de) | 2006-05-18 |
EP0933993A1 (en) | 1999-08-11 |
NZ333437A (en) | 2000-05-26 |
ES2263179T3 (es) | 2006-12-01 |
PT933993E (pt) | 2006-10-31 |
CN1227466A (zh) | 1999-09-01 |
NO985821L (no) | 1999-02-10 |
RO121027B1 (ro) | 2006-11-30 |
CA2258217C (en) | 2005-08-09 |
JP3481255B2 (ja) | 2003-12-22 |
AU723360B2 (en) | 2000-08-24 |
US6410594B1 (en) | 2002-06-25 |
EP0933993A4 (en) | 2004-09-08 |
NO985821D0 (no) | 1998-12-11 |
EP0933993B1 (en) | 2006-04-05 |
CZ412898A3 (cs) | 1999-08-11 |
PL330407A1 (en) | 1999-05-10 |
AU3475097A (en) | 1998-01-07 |
DK0933993T3 (da) | 2006-08-14 |
ATE322163T1 (de) | 2006-04-15 |
KR20000016669A (ko) | 2000-03-25 |
SK171698A3 (en) | 1999-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000505088A (ja) | ノイラミニダーゼ阻害剤として有用なシクロペンタン置換化合物 | |
EP1040094B9 (en) | Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors | |
DE69635231T2 (de) | Selektive Inhibitoren viraler oder bakterieller Neuraminidase | |
US6509359B1 (en) | Pyrrolidin-2-one compounds and their use as neuraminidase inhibitors | |
EP0415850A1 (fr) | Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
JPS6323897A (ja) | タフトシン類似体、その製法及び医薬組成物 | |
JP2002521312A (ja) | ノイラミニダーゼの阻害剤 | |
EP2952517B1 (en) | Compound having lysophosphatidylserine receptor function modulation activity | |
CN114437043B (zh) | 一种抗新冠药物Nirmatrelvir的制备方法 | |
JPH10502050A (ja) | 骨関節疾患の治療に有用なn−〔{4,5−ジヒドロキシ−及び4,5,8−トリヒドロキシ−9,10−ジヒドロ−9,10−ジオキソ−2−アントラセン−イル}カルボニル〕アミノ酸 | |
NZ520724A (en) | Tetrahydro-pyridine compounds for inhibiting neuraminidase and treating influenza neuraminidase | |
US6762316B1 (en) | Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates | |
EP1189862A1 (en) | Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates | |
EP0564658B1 (en) | 2-(2,3-dicarboxycyclopropyl)glycine and method for producing the same | |
AU2003212040C1 (en) | Substituted Cyclopentane And Cyclopentene Compounds Useful As Neuraminidase Inhibitors | |
AU5341198A (en) | Substituted propionyl derivatives | |
MXPA98010617A (en) | Cyclopentine compounds substituted useful as inhibitors of neuraminid | |
AU4259500A (en) | Novel compounds and methods for synthesis and therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D04 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081010 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091010 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101010 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111010 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121010 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131010 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |